With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

Klarity - Weight Loss Looking for weight loss options? GLP-1 agonist medications, originally designed to manage type 2 ...

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...